Stakes In Health Reform Especially High For Women, Christian Science Monitor Reports

Women have a particularly high stake in the health care reform debate because they "interact with the health care system more often" than men, "and so are more vulnerable to a system with soaring costs and with restrictions that hurt women especially," the Christian Science Monitor reports.

Dialysis Patients Often Not Told About Transplant Options, Newspaper Reports

"Thousands of kidney patients in the United States start dialysis without first being told of kidney transplants that would be cheaper and lead to longer lives, according to a four-month newspaper investigation published Sunday," The Associated Press reports. The Pittsburgh Tribune-Review reviewed U.S.

G20 Addresses Food Aid, Advocates React To Commitments

The G20 said the World Bank trust fund for agricultural investment in poor countries that they called for on Friday "should be designed so that money will be disbursed quickly and countries can decide for themselves where they want it spent," Reuters reports.

Nanotech Research Featured In Nature Nanotechnology Journal

Using an RNA-powered nanomotor, University of Cincinnati (UC) biomedical engineering researchers have successfully developed an artificial pore able to transmit nanoscale material through a membrane. In a study led by UC biomedical engineering professor Peixuan Guo, PhD, members of the UC team inserted the modified core of a nanomotor, a microscopic biological machine, into a lipid membrane.

Flexible Stenting Solutions, Inc. Receives Conditional IDE Approval For FlexStent(R) Femoropopliteal Self Expanding Stent System

Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, announced that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.

DiscoveryBioMed, Inc. Awarded Phase 2 SBIR Grant By The NIH To Discover Hypertension And Cystic Fibrosis (CF) Drugs

DiscoveryBioMed, Inc. (DBM) announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and chronic kidney diseases with hypertension.